Nuclear hormone receptors of the NR4A subfamily are rapidly induced during the early stages of adipogenesis, leading to the speculation that they may have important roles in this process. One of the three subfamily members, Nur77 has also been shown to play key roles in energy expenditure and lipolysis in skeletal muscle and in the control of hepatic gluconeogenesis. We, therefore, examined the role of NR4A factors in adipogenesis using the well-characterized 3T3-L1 preadipocyte model. Inhibition of Nur77 expression using siRNA did not affect induction of adipogenic genes, nor the accumulation of lipid. To inhibit the activity of all the three NR4A family members, we generated preadipocytes stably expressing a well-characterized dominant-negative Nur77 (DN-Nur77), known to block the function of the other NR4A factors, Nurr1 and Nor1, as well as Nur77. While the increased NR4A activity observed following adipogenic induction was completely abolished in these cells, DNNur77 expression did not affect the expression of genes characteristic of terminally differentiated adipocytes and had no impact on lipid accumulation in these cells. Thus, while members of the NR4A subfamily of nuclear receptors may have important metabolic roles in skeletal muscle and liver, we demonstrate that they are dispensable for normal adipocyte development.
Introduction
Inappropriately increased or decreased adipose tissue mass, as occurs in syndromes of obesity and lipodystrophy, respectively, are strongly associated with metabolic disease. [1] [2] [3] [4] This demonstrates the critical physiological importance of maintaining adipose mass within tightly defined limits. Increased adiposity involves increases in fat-cell size and also new adipocyte formation through adipogenesis. 1, [5] [6] [7] Thus, a greater understanding of the molecular basis of adipogenesis may suggest rational therapeutic strategies aimed at manipulating adipocyte development as a means of treating disorders of adipose tissue mass. Adipogenesis requires a highly orchestrated program of gene expression. Hormonal stimulation initially leads to the transient induction of factors including CCAAT/enhancerbinding proteins C/EBPb and C/EBPd. These events prime the subsequent induction of the master differentiation factors C/ EBPa 8 and the peroxisome proliferator activator receptor g (PPARg). 9 C/EBPa and PPARg, then induce genes characteristic of terminally differentiated, insulin-sensitive lipid-laden adipocytes. Recent advances have identified numerous additional pro-and anti-adipogenic factors including, among others, KLF5, KLF15, Krox20, Stat5A, GATA2/3, CHOP and ETO (reviewed by Rosen and MacDougald 10 ). However, this complex transcriptional program, particularly the early commitment of preadipocytes, seems to involve multiple factors yet to be identified. The NR4A family of orphan nuclear receptors comprises three closely related proteins, Nur77, Nurr1 and Nor1. Previous high-throughput expression studies have shown that these proteins are strongly induced during early adipogenesis. 11, 12 This has led to direct speculation by others that these factors may contribute significantly to the transcriptional regulation of this process, although their importance was not experimentally tested in these studies. The recent demonstration that Nur77 regulates lipolysis in skeletal muscle cells 13 and hepatic gluconeogenesis, 14 highlights its potential importance in energy metabolism. The metabolic role of Nur77 in other tissues and the direct speculation by others that NR4A factors might play a key role, led us to investigate their role in adipogenesis.
To examine the importance of Nur77 in adipogenesis, we inhibited its expression by RNA interference. Synthetic double-stranded siRNAs (small interfering RNAs) targeting mouse Nur77 (si-Nur77) were transfected into 3T3-L1 preadipocytes. Briefly, siRNA/liposome mixtures containing 2 mg of LipofectAMINE 2000 (Invitrogen, Paisley, UK) and 100 nM of siRNA per well were incubated for 20 min at room temperature, then added to the cells and incubated for 6 h in the presence of serum before replacement with fresh medium. After 18 h adipogenesis was induced as described previously. 15 Transfection efficiency, monitored by transfection of a FITC-labelled siRNA in a separate well, was approximately 90%. RNA isolated from these cells at various time points during differentiation was reverse transcribed into cDNA as described previously. 15 Consistent with the previously published studies, Nur77 mRNA expression was rapidly and transiently induced following the addition of adipogenic stimuli in cells transfected with negative control siRNA. In contrast, si-Nur77 reduced the peak of Nur77 induction by more than 70%, demonstrating an efficient targeting of the Nur77 mRNA ( Figure 1a ). Western blotting demonstrated that si-Nur77 transfection led to a significant suppression of Nur77 protein expression consistent with that observed for its mRNA ( Figure 1b ). Next we examined the expression of a number of key adipogenic markers to define any effect of Nur77 knockdown on adipocyte differentiation. Despite very substantial inhibition of Nur77 expression, we could not detect any significant allied to the gene expression data, it clearly demonstrates that the specific knockdown of Nur77 expression had no major effect on adipogenesis. Nur77, Nurr1 and Nor1 exhibit redundancy in many of their reported functions. 16, 17 Moreover, previous microarray analyses of nuclear hormone receptor expression have demonstrated that, like Nur77, Nurr1 and Nor1 are rapidly and transiently induced in differentiating 3T3-L1 preadipocytes, raising the possibility that they may compensate for the loss of Nur77 in our cells. To test this, we employed an N-terminally truncated dominant-negative form of Nur77, which has been extensively characterized in several studies and exerts a strong dominant-negative effect against all members of the NR4A family. [16] [17] [18] Wild-type and dominantnegative Nur77 (DN-Nur77) were subcloned into the retroviral pBabe vector, retroviruses were generated and used to infect 3T3-L1 preadipocytes to produce stable cell lines. Mock-transfected cells were generated by infection with empty virus. Western blotting analysis demonstrated that exogenous DN-Nur77 protein was expressed at a high level (Figure 2a ). To functionally validate the efficacy of dominant negativity of DN-Nur77 over NR4A members, we employed an Nur response element promoter-luciferase reporter gene construct (pLuc-NurRE), that has previously been shown to bind to and be activated by all NR4A factors. 19 This allowed the direct determination of the transcriptional activity of NR4A factor in mock-infected, Nur77-overexpressing and DN-Nur77-expressing cells. Cells were incubated with a DNA/liposome mix containing 1 mg LipofectAMINE 2000 (Invitrogen), 0.5 mg pLuc-NurRE plasmid and 0.05 mg pRL-CMV plasmid per well for 30 min. The pRL-CMV plasmid (Promega, Southampton, UK) coding for Renilla luciferase was cotransfected as an internal control for transfection efficiency. After 4 h, medium was replaced with 3T3-L1 growth medium for 16 h, followed by stimulation of adipocyte differentiation for 0, 8 or 24 h. Cells were subsequently lysed and luciferase activities assayed using a dual luciferase reporter system (Promega).
In mock-infected cells expressing only endogenous NR4A proteins, luciferase activity increased approximately five-fold within 8 h following treatment with MDI (IBMX, Dexamethasone and Insulin) (Figure 2b) , coincident with the induction of Nur77, Nurr1 and Nor1 expression (Figure 2c ). This demonstrates that the induction of these genes results in transcriptional activity, measurable using this assay. In contrast, cells expressing the DN-Nur77 failed to show any induction of NurRE promoter activity following adipogenic stimulation (Figure 2b) . As a control, and consistent with its overexpression, cells constitutively expressing wild-type Nur77 showed similarly/equally strong NurRE promoter activity at all time points. While this does not assay the effect of DN-Nur77 on specific promoters, the use of the generic pLuc-NurRE reporter detects any NR4A factor activity present in these cells. Thus, these data strongly suggest that DN-Nur77 can efficiently block the activity of all NR4A orphan nuclear receptors in differentiating 3T3-L1 preadipocytes.
Next we examined the expression of several key adipogenic marker genes in 3T3-L1 cells expressing DN-Nur77. Figure 2g ). It is recently been reported that, in skeletal muscle myotubes, Nur77 regulates expression of glucose transporter-4 (GLUT4) and uncoupling protein-3 (UCP3), 13 both of which are increased during adipocyte differentiation. However, neither GLUT4 (Figure 2h ) nor UCP3 (Figure 2i ) mRNA expression was altered in cells expressing DN-Nur77, suggesting that this regulatory role for NR4A factors in skeletal muscle is not active during adipogenesis. Finally, we examined overall lipid accumulation by Oil Red O staining and, consistent with the unaltered expression of key adipogenic markers, failed to detect any differences between DN-Nur77-expressing mock-infected cells (Figure 2j ). 3T3-L1 cells have proven to be a robust model system for identifying important regulators of adipogenesis, thus, we would expect to detect any significant role of NR4A factors in our experiments. However, considerable redundancy probably exists in adipocyte development, so we cannot entirely exclude a role of NR4A factors in adipogenesis. The induction of NR4A factors is transient, occurring only early in adipogenesis, suggesting it is unlikely to directly regulate mature adipocyte characteristics such as insulin sensitivity. Interestingly, NR4A inhibition does not cause any change in the proliferative step that occurs in early adipogenesis (data not shown). 
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While we were completing this work, Fumoto et al. 20 reported that knockdown of Nur77 led to minor decreases in PPARg, C/EBPa and perilipin during early differentiation which were not sustained. They concluded that Nur77 may regulate adipogenesis; however, the effects they observed were weak. The reason for the minor differences between our studies is not clear; however, Fumoto et al. 20 use lentiviruses that are delivered when the cells are only 30% confluent. 3T3-L1 differentiation is very sensitive to the confluence of cells at the time of induction. Even if lentiviral knockdown of Nur77 in pre-confluent 3T3-L1 cells produce subtle differences in proliferation and so cell density at induction, this could result in the minor changes in adipogenesis, and might explain the effects they observed. Unlike Fumoto et al., we examined the expression of other NR4A factors and inhibited their activity without significant effect on adipogenesis. We believe that, when all the data are considered, both studies support our conclusion that NR4A factors are dispensable for adipogenesis.
In conclusion, microarray analyses of differentiating preadipocytes have highlighted a plethora of highly regulated transcription factors. However, meticulous loss-or gain-of-function experiments are required to dissect their importance in adipogenesis. The dramatic induction of NR4A transcription factors led us, and others, to speculate that they may play important roles in adipogenesis. However, our data strongly suggest that NR4A transcription factors have no essential role in the transcriptional control of early adipogenesis, nor in lipid accumulation in the mature adipocyte.
